Adenosine deaminase activity in the aetiological diagnosis of community-acquired pneumonia

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 3, 1997, Pages 287-290

  Molinos, Luis ^a   Fernandez, Ramon ^a   Dominguez, Maria J ^a   Riesgo, Carlos ^a   Escudero, Carlos ^a   Martinez, Jaime ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXIELLA BURNETII; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA; PROSPECTIVE STUDY;

EID: 0030803558     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709019044     Document Type: Article

References (23)

1. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, aetiology, and impact. Am J Med 78 Suppl 6B: 32-37, 1985.
2. MacFarlane J. Community-acquired pneumonia. Br J Dis Chest 81: 116-127, 1987.
3. Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148: 1418-1426, 1993.
4. Holmberg H, Bodin L, Jönsson I, Krook A. Rapid aetiological diagnosis of pneumonia based on routine laboratory features. Scand J Infect Dis 22: 537-545, 1990.
5. Örtqvist A, Hedlund J, Wretlind B, Carlström A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 27: 457-462, 1995.
6. MacFarlane J. Treatment of lower respiratory tract infections. Lancet 2: 1446-1449, 1987.
7. Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J 2: 1751-1752, 1987.
8. Biberfeld G, Biberfeld P, Sterner G. Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I: Lymphocyte stimulation. Clin Exp Immun 17: 29-41, 1974.
9. Young E, Taylor HR. Immune mechanisms in chlamydial eye infections: cellular immune responses in chronic and acute disease. J Infect Dis 150: 745-751, 1984.
10. Bañales JL, Pineda PR, Fitzgerald JM, Rubio H, Selman M, Salazar-Lezama M. Adenosine deaminase in the diagnosis of tuberculous pleural effusions. A report of 218 patients and review of the literature. Chest 99: 355-357, 1991.
11. Nishikawa H, Suga M, Ando M, Tanaka F, Araki S. Serum adenosine deaminase activity with Mycoplasma pneumoniae [letter]. Chest 94: 1315, 1988.
12. Klockars M, Kleemola M, Leinonen M, Koskela M. Serum adenosine deaminase in viral and bacterial pneumonia. Chest 99: 623-626, 1991.
13. Suga M, Ando M, Nishikawa H, Araki S. Adenosine deaminase activity and free IL-2 receptor levels in serum from patients with Mycoplasma pneumoniae. Jpn J Med 30: 108-112, 1991.
14. Fernández R, Molinos L, Díaz B, Domínguez MJ, Riesgo C, Ramos S, Martinez J. Serum adenosine deaminase (ADA) activity in community acquired pneumonia (CAP): its diagnostic value (abstract). Eur Respir J 6 Suppl 7: 635S, 1993.
15. Ungerer JP, Oesthuizen NM, Paissbart SM, Vermaak JM. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem 38: 1322-1326, 1992.
16. Giusti G. Adenosine deaminase. In: Bergmayer MV, ed. Methods of enzymatic analysis. 2nd ed. New York: Academic Press, 1092-1099, 1974.
17. Griner PF, Mayewski RJ, Mushlin AI, Grunland P. Selection and interpretation of diagnostic tests and procedures. Ann Intern Med 94: 533-600, 1981.
18. Hovi T, Smith JF, Allison AC, Williams SC. Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immun 23: 395-403, 1976.
19. Gakis C, Calia G, Naitana A, Pirino D, Serru G. Serum adenosine deaminase activity in HIV positive subjects. A hypothesis on the significance of ADA2. Panminerva Med 31: 107-113, 1989.
20. 2: diagnostic and biological role. Eur Respir J 9: 632-633, 1996.
21. Kauppinen MT, Herva E, Kujala P, Leinonen M, Saikku P, Syrjälä H. The aetiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 172: 1330-1335, 1995.
22. The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 49: 346-350, 1993.
23. Normativa SEPAR sobre el diagnóstico y tratamiento de las neumonias. Barcelona. Ediciones Doyma, 1-52, 1992.